drugset / Trial / NCT03504956

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

NCT03504956

Recruiting 150 enrolled Cedars-Sinai Medical Center
Non-randomizedSingle-groupOpen-labelOther

Summary

This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.

Timeline

Start
2018-07-30
Primary completion
2025-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Gadobutrol Diagnostic / imaging agent 0.2 unknown Intravenous
Background Metoprolol Other / unclassified Oral